About
All Posts
Partner
Logo
Login
Subscribe
Logo
  • Home
  • Posts
  • Moonshot’s Kimi K2.5 open model on par with GPT-5.2, Opus 4.5

Jan 27, 2026

Moonshot’s Kimi K2.5 open model on par with GPT-5.2, Opus 4.5

Bay Area Times
Bay Area Times
Moonshot’s Kimi K2.5 open model on par with GPT-5.2, Opus 4.5

Brought to you by:

Top stories today:

  1. Moonshot’s Kimi K2.5 open model on par with GPT-5.2, Opus 4.5
  2. OpenAI said to target ~$60 CPM for ChatGPT ads
  3. Ricursive, by ex-Google researchers, raises $335M at $4B valuation
  4. NVIDIA invests $2B more in CoreWeave to expand 5GW+ AI capacity
  5. Microsoft unveils Maia 200 as Azure’s next-gen AI chip
  6. Alibaba’s closed Qwen3-Max-Thinking claims GPT-5.2-level reasoning

Follow us on X | Instagram | Advertise

0. Data and calendar

All values as of 6 AM ET / 3 AM PT, other than S&P500 and NASDAQ close (4 PM ET / 1 PM PT).

All times are ET.

Listen to our AI-generated podcast summarizing today’s newsletter (beware of hallucinations):

1. Moonshot’s Kimi K2.5 open-weights model on par with GPT-5.2, Opus 4.5, Gemini 3 Pro

Across major benchmarks, according to Moonshot:

X: Moonshot.

  • The model is live on Kimi.com in chat and agent modes.

  • K2.5 Agent Swarm is available in beta for high-tier users.

  • Weights are available through Hugging Face.

  • Chinese AI company.

  • DeepSeek has been teasing its next major release in recent weeks but without specifics.

2. OpenAI said to target ~$60 CPM for ChatGPT ads in early premium push

  • OpenAI reportedly won’t initially provide detailed data on ad context or user conversions.

  • Early advertisers will get basic metrics such as impressions and total clicks.

  • High-level insights like total ad views will be provided, an OpenAI spokesperson confirmed.

  • OpenAI’s partnership team has already made some early ad sales, including with existing enterprise customers.

  • Many advertisers are likely to hold off on major spend until there’s evidence ads drive sales.

3. Tomorrow.bio is leading human cryopreservation across Europe and the US*

Tomorrow.bio.

  • We provide human cryopreservation, using extremely low temperatures to stop biological processes in the body. Patients are cryopreserved in the expectation that future technology may be able to revive them and treat their underlying cause of death.

  • We’ve improved all aspects of human cryopreservation, including patient storage, by building a secure long-term facility in Switzerland where patients are stored indefinitely until revival may one day be possible.

  • Membership includes cost savings on cryopreservation costs and access to our community and resources. Use code BAY10 for 10% off when you’re ready. Start by learning how cryopreservation actually works on our site.

Learn more

*Bay Area Times partner.

4. Ricursive, by ex-Google researchers, raises $335M at $4B valuation 2 months after launch

NYTimes: Ricursive co-founders Anna Goldie and Azalia Mirhoseini.

Subscribe to keep reading

This content is free, but you must be subscribed to Bay Area Times to continue reading.

Already a subscriber?Sign in.Not now

Keep reading

Jul 27, 2026

Claude Opus 5 debuts, nears Fable 5 performance at 50% lower price

Claude Opus 5 debuts, nears Fable 5 performance at 50% lower price

Jul 24, 2026

ChatGPT Health expands to all U.S. adult users

ChatGPT Health expands to all U.S. adult users

Jul 23, 2026

Alphabet Q2 revenue +24% YoY to $119.8B, vs. $116.9B est., net income +298%

Alphabet Q2 revenue +24% YoY to $119.8B, vs. $116.9B est., net income +298%

Jul 22, 2026

OpenAI says GPT-5.6 Sol and “even more capable pre-release” AI model breached Hugging Face

OpenAI says GPT-5.6 Sol and “even more capable pre-release” AI model breached Hugging Face

Subscribe

Your morning briefing, free forever.

Get the latest news, resources, and more delivered straight to your inbox everyday.

The visual daily newsletter on business and tech. Analyzing the news with 1 visual per story. Join our 250,000+ subscribers here.

Copyright © 2026 Bay Area Times.

BAT

Company

Legal

Privacy Policy

Terms of Service